France· FR:61768865
LACRYVISC, gel ophtalmique en récipient unidose
A medicinal product containing carbomère 974p, registered in France by LABORATOIRES ALCON, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CARBOMÈRE 974P
- Manufacturer
- LABORATOIRES ALCON
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093425289130 récipient(s) unidose(s) polyéthylène de 0,5 gEUR 3.37
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carbomère 974p in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAaCarb Carbomer 0.2% eye gelTriOn Pharma Ltd
- SpainLACRYVISC 3 mg/g GEL OFTALMICOAlcon Healthcare S.A.
- PolandOftagelSanten Oy
- GermanyCarbomer EdoDr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh
- NetherlandsCarbomeer Medcor één dosis ooggel 2 mg/gMedcor Pharmaceuticals B.V.
- IrelandGeltears 0.2 % w/w carbomer eye gelBausch + Lomb Ireland Limited
- IcelandOftagelSanten Oy*
- FinlandLiposicDr. Gerhard Mann, Chem.-pharm. Fabrik GmbH
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Carbomer Agepha
- Belgium · Liposic
- Germany · Carbomer Edo, Liposic
- Denmark · Viscotears
- Spain · Lipolasic
- Finland · Viscotears
- United Kingdom (Northern Ireland) · Viscotears, Viscotears Single Dose Unit
- Greece · Liposic, Viscoter
- Ireland · Geltears, Liposic
- Iceland · Vidisic
- Italy · Lipovisc
- Luxembourg · Vidisic Edo, Vidisic®
- Netherlands · Liposic, Vidisic Carbogel
- Norway · Viscotears
- Poland · Vidisic
- Portugal · Liposic
- Sweden · Viscotears
- Slovakia · Vidisic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd27a8ed-0317-4d96-af9a-a7e20f6bc246 GET /v1/drugs/dd27a8ed-0317-4d96-af9a-a7e20f6bc246?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61768865",
"date_amm": "1992-02-21",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CARBOMÈRE 974P",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "gel",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about carbomère 974p.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.